Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-α and interleukin-1β concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 3, 1998, Pages

  Oygür, Nihal ^a   Sönmez, Özlem ^a   Saka, Osman ^c   Yeǧin, Olcay ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Division of Immunology

^c Department of Biostatistics ^*

Author keywords

Cytokine; Hypoxic ischaemic encephalopathy; Interleukin 1 ; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; INFANT; PRIORITY JOURNAL;

EID: 0031741664     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.3.F190     Document Type: Article

References (24)

1. Vannuci RC. Hypoxia-ischemia: Clinical aspects. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. Diseases of the Fetus and Infant. 6th edn. Philadelphia: Mosby Year Book, 1997:877-91
2. Pasternak JF. Hypoxic-ischemic brain damage in the term infant. Pediatr Clin North Am 1993;40:1061-71.
3. Robertson CMT, Finer NN. Long term follow-up of term neonates with perinatal asphyxia. Clin Perinatol 1993;20:483-90.
4. Bont ESJM, Martens A, Raan J, et al. Tumor necrosis factor-alpha, interleukin-1B and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res 1993;33:380-3.
5. Özdemir A, Oygür N, Gültekin M, Copkun M, Yeǧin O. Neonatal tumor necrosis factor, interleukin-1alpha, interleukin-1B and interleukin-6 response to Infection. Am J Perinatol 1994;11:282-4.
6. Nelson KB, Emery ES. Birth asphyxia and the neonatal brain: What do we know and when do we know it? Clin Perinatol 1993;20:327-44.
7. Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995;26:1093-100.
8. Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int 1997;30:375-83.
9. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress:a clinical and electrophysiological study. Arch Neurol 1976;33:696-701
10. Fee SC, Malee K, Deddish R, Minogue JP, Min D, Socol ML. Severe acidosis and subsequent neurologic status. Am J Obset Gynecol 1990;162:802-6.
11. Nelson KB, Ellenberg JH. Apgar scores as predictors of chronic neurologic disability. Pediatrics 1981;68:36-44.
12. Carter BS, MAJ, Haverkamp AD, Merestein GB. The definition of acute asphyxia. Clin Perinatol 1993;20:287-303.
13. Hellström-Westas L, Rosen I, Svenningsen NW. Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants. Arch Dis Child 1995;72:F34-38.
14. Eken P, Toet MC, Groenendaal F, de Vries LS. Predictive value of early neuroimaging, pulsed Doppler and neurophysiology in fullterm infants with hypoxic-ischaemic encephalopathy. Arch Dis Child 1995,73:F75-80.
15. Martin E, Barkovich AJ. Magnetic resonance imaging in perinatal asphyxia. Arch Dis Child 1995;72:F62-70.
16. Rutherford M, Pennock J, Schwieso J, Cowan F, Dubowitz L. Hypoxic-ischaemic encephalopathy:early and late magnetic resonance imaging findings in relation to outcome. Arch Dis Child 1996;75:F145-51.
17. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-9.
18. Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994;130:362-7.
19. Ancel AM, Alix-AG, Salcedo DP, Cabanas F, Valcarce M, Quero J. Interleukin-6 in the cerebral fluid after perinatal asphyxia is related to early and late neurologic manifestations. Pediatrics 1997;100:789-94.
20. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an antiinflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor. Blood 1994;83:113-18.
21. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990;144:129-35.
22. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL. Recombinant human IL-6 supresses demyelination in a viral model of multihple sclerosis. J Immunol 1994;153:3811-21.
23. Azzopardi D, Wyatt JS, Cady EB, et al. Prognosis of newborn infants with hypoxic-Ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 1989;25:445-51.
24. Mehmet H, Edwards AD. Hypoxia, ischaemia, and apoptosis. Arch Dis Child 1996;75:F73-5.